Epivax Secures Additional Funding From Fda For Immunogenicity Risk Assessment For Biosimilar Products
Round Type
Funding Round
ProvidenceBiotechnologyDescription
EpiVax, Inc. ("EpiVax") is pleased to announce the award of a two-year, $2 million grant from the FDA's Office of Center for Drug Evaluation and Research (CDER) to validate a method for immunogenicity risk assessment of host cell proteins (HCP) for improving biosimilar product development and assessing product interchangeability (# U01FD007760). The research will commence in September 2022 and conclude in August 2024.
Quick answer
EpiVax raised an undisclosed amount in a Funding Round round, dated September 12, 2022. EpiVax is based in Providence, Rhode Island, United States.
- How much did EpiVax raise?
- EpiVax raised an undisclosed amount in a Funding Round round on September 12, 2022.
- What does EpiVax do?
- EpiVax has developed advanced immunogenicity risk assessment tools (ISPRI and ISPRI-HCP) that are used by top tier biologics developers around the globe.
- Where is EpiVax based and how big is it?
- EpiVax is based in Providence, Rhode Island, United States. Fundz records about 48 employees.
- Who are the decision-makers at EpiVax?
- Fundz holds 1 contact at EpiVax. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as EpiVax that raised within 45 days of this round, from Fundz verified event records.
- Lazzaro Medical raised $1M (Seed) on October 27, 2022.
- Monteris Medical raised $73M (Debt Financing) on October 27, 2022.
- Tetra Bio-Pharma Inc. raised an undisclosed amount (Funding Round) on October 27, 2022.
- PTC Therapeutics raised an undisclosed amount (Funding Round) on October 27, 2022.
- Cresilon raised $25M (Series A) on October 27, 2022.
- Aravive Biologics, Inc. raised $42M on October 27, 2022.
Who to call at EpiVax, and when
A new round usually means EpiVax is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day EpiVax raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at EpiVax, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at EpiVax. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment EpiVax raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
EpiVax raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.